Skip to content

    Recently Viewed

      Listening...

      Lede-What You Need to Know About Johnson & Johnson's 2021 First-Quarter Earnings.jpg

      What you need to know about Johnson & Johnson’s 2021 first-quarter earnings

      Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

      Share Article
      share to
      90.png

      This morning, Johnson & Johnson shared its first-quarter performance.

      For more than 130 years, the company has aimed to make people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, with approximately 135,000 employees across the globe, the organization is striving to put a healthy mind, body and environment within reach of everyone, everywhere.

      “Our strong first-quarter performance was primarily driven by above market growth in our pharmaceutical segment and continued recovery in our medical device unit,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are more confident than ever in the resilience of our diversified portfolio and the unwavering commitment of our Johnson & Johnson colleagues to deliver life-enhancing medicines and products to patients and customers around the globe. We remain focused on creating long-term value for all our stakeholders and investing in innovation that helps to further our goal of changing the trajectory of health for humanity.”

      For more details about the company’s 2021 first-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


      2021 Johnson & Johnson First Quarter Earnings Infographic

      Johnson & Johnson’s 2021 1st-Quarter Earnings

      Read the earnings press release, which includes full financial details for the first quarter of 2021.

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Caring & giving
      Sam Seavey piloting an aircraft from the cockpit

      3 health advocates; 1 Johnson & Johnson program that offers empowerment and connection

      In the quest to solve the toughest health challenges, innovating therapies and finding treatments are essential—but so is supporting the patients living with these diseases. That’s exactly why Johnson & Johnson launched HealtheVoices a decade ago.
      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.